{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -5.000003, "regularMarketPrice": 0.19, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.3, "sharesOutstanding": 35039100, "bookValue": 0.064, "fiftyDayAverage": 0.20918, "fiftyDayAverageChange": -0.01918, "fiftyDayAverageChangePercent": -0.09169137, "twoHundredDayAverage": 0.28481, "twoHundredDayAverageChange": -0.09481001, "twoHundredDayAverageChangePercent": -0.3328886, "marketCap": 8002363, "priceToBook": 2.9687498, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1628834400000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "AWAKN LIFE SCIENCES CORP", "longName": "Awakn Life Sciences Corp.", "messageBoardId": "finmb_673256170", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.010000005, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.19, "regularMarketDayRange": "0.189 - 0.19", "regularMarketDayLow": 0.189, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.2, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "CAD", "regularMarketOpen": 0.189, "averageDailyVolume3Month": 108, "averageDailyVolume10Day": 100, "fiftyTwoWeekLowChange": 0.067999996, "fiftyTwoWeekLowChangePercent": 0.55737704, "fiftyTwoWeekRange": "0.122 - 0.97", "fiftyTwoWeekHighChange": -0.78000003, "fiftyTwoWeekHighChangePercent": -0.8041237, "fiftyTwoWeekLow": 0.122, "fiftyTwoWeekHigh": 0.97, "symbol": "954.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "301-217 Queen Street West", "city": "Toronto", "state": "ON", "zip": "M5V 0R2", "country": "Canada", "website": "https://awaknlifesciences.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. The company is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Anthony  Tennyson", "title": "Co-founder, Pres, CEO & Director", "fiscalYear": 2021, "totalPay": {"raw": 51093, "fmt": "51.09k", "longFmt": "51,093"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James  Collins", "title": "Chief Operating Officer", "fiscalYear": 2021, "totalPay": {"raw": 7246, "fmt": "7.25k", "longFmt": "7,246"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shaun  McNulty Ph.D.", "title": "Chief Scientific Officer & Member of Pre-Clinical Advisory Board", "fiscalYear": 2021, "totalPay": {"raw": 10698, "fmt": "10.7k", "longFmt": "10,698"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. George  Scorsis", "age": 45, "title": "Co-founder & Chairman", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan James Held C.A., CPA, CA", "age": 36, "title": "Co-Founder & CFO", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gordo  Whittaker", "title": "Chief Marketing Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Naomi  Junghae", "title": "Human Resource Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D.", "title": "Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Celia  Morgan", "title": "Head of Ketamine-Assisted Therapy & Member of Clinical Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lowan H. Stewart F.A.C.E.P., M.D.", "title": "Regional Director of Nordics & MD of Awakn Oslo AS", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}